Research Article

Evaluation of Turkish validity and reliability of the cancer stigma scale

Volume: 21 Number: 2 August 23, 2023
TR EN

Evaluation of Turkish validity and reliability of the cancer stigma scale

Abstract

Objective: In this study, it was aimed to evaluate the Turkish validity and reliability of the Cancer Stigma Scale (CASS) in women who applied for cancer screening. Methods: After the translation and cultural adaptation phase of CASS was completed, the Turkish version (T-CASS) was applied to 500 women who applied for cancer screening between December 2, 2019 and January 26, 2020, by face-to-face interview technique. The reliability of T-CASS was evaluated with internal consistency analysis and test-retest analysis. Cronbach Alpha internal consistency coefficient was calculated to evaluate internal consistency. The validity of the T-CASS was evaluated by content validity (according to the Davis technique) and construct validity. The accuracy of the six sub-dimensional structures was tested with first and second level Confirmatory Factor Analysis (CFA). Results: Cronbach’s alpha coefficient for the T-CASS was 0.659. Test-retest total scores of the T-CASS showed “moderate” correlation (r=0.488, p<0.001). The content validity results showed that all items were suitable for language validity according to the Davis Technique. According to the results of first and second order CFA, fit indices demonstrated a very good model fit. Conclusion: It was concluded that T-CASS is a "valid" and "moderately reliable" scale that can be used to measure cancer stigma in groups of women with similar sociodemographic characteristics.

Keywords

atiitude, early detection of cancer, scale, stigma, validity and reliability

References

  1. T. C. Sağlık Bakanlığı. Türkiye Kanser Kontrol Programı 2016. [online]. Available at:https://hsgm.saglik.gov.tr/depo/birimler/kanserdb/yayinlar/raporlar/Ulusal_ Kanser_Kontrol_Plani_2013_2018.pdf Accessed March 19,2020.
  2. World Health Organization. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. [online]. Available at:https://www.who.int/cancer/PRGlobocanFinal.pdf?ua=1; Accessed April 29,2019.
  3. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Kanser Taramaları. [online]. Available at:https://hsgm.saglik.gov.tr/tr/kanser-taramalari; Accessed April 29,2019.
  4. World Health Organization. Cancer. [online]. Available at:https://www.who.int/cancer/en/; Accessed April 29,2019.
  5. Özmen S, Erdem R. Damgalamanın Kavramsal Çerçevesi. Süleyman Demirel Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi, 2018; 23 (1).
  6. Goffman E. Stigma: Notes On The Management of Spoiled Identity. ABD: Prentice-Hall. 1963.
  7. Shiri FH, Mohtashami J, Nasiri M, Manoochehri H, Rohani C. Stigma and related factors in Iranian people with cancer. Asian Pacific journal of cancer prevention: APJCP. 2018;19(8):2285.
  8. Cho J, Smith K, Choi EK et al. Public Attitudes Toward Cancer and Cancer Patients: A National Survey in Korea. PsychoOncology 2012;22:605–613. 13
  9. Cho J, Choi EK, Shin DW et al. Association Between Cancer Stigma and Depression among Cancer Survivors: A Nationwide Survey in Korea. Psycho‐Oncology, 2013, 22.10: 2372-8.
  10. World Health Organization. Guide to cancer early diagnosis. [online]. Available at:https://apps.who.int/iris/bitstream/handle/10665/254500/9789241511940- eng.pdf;jsessionid=D29D31D99439A4EB6B420E30C51C3383?sequence=1 [online]. Accessed April 29,2019.
APA
Susuz, Ç., & Özvarış, Ş. B. (2023). Evaluation of Turkish validity and reliability of the cancer stigma scale. Turkish Journal of Public Health, 21(2), 196-208. https://doi.org/10.20518/tjph.1165240
AMA
1.Susuz Ç, Özvarış ŞB. Evaluation of Turkish validity and reliability of the cancer stigma scale. TJPH. 2023;21(2):196-208. doi:10.20518/tjph.1165240
Chicago
Susuz, Çağla, and Şevkat Bahar Özvarış. 2023. “Evaluation of Turkish Validity and Reliability of the Cancer Stigma Scale”. Turkish Journal of Public Health 21 (2): 196-208. https://doi.org/10.20518/tjph.1165240.
EndNote
Susuz Ç, Özvarış ŞB (August 1, 2023) Evaluation of Turkish validity and reliability of the cancer stigma scale. Turkish Journal of Public Health 21 2 196–208.
IEEE
[1]Ç. Susuz and Ş. B. Özvarış, “Evaluation of Turkish validity and reliability of the cancer stigma scale”, TJPH, vol. 21, no. 2, pp. 196–208, Aug. 2023, doi: 10.20518/tjph.1165240.
ISNAD
Susuz, Çağla - Özvarış, Şevkat Bahar. “Evaluation of Turkish Validity and Reliability of the Cancer Stigma Scale”. Turkish Journal of Public Health 21/2 (August 1, 2023): 196-208. https://doi.org/10.20518/tjph.1165240.
JAMA
1.Susuz Ç, Özvarış ŞB. Evaluation of Turkish validity and reliability of the cancer stigma scale. TJPH. 2023;21:196–208.
MLA
Susuz, Çağla, and Şevkat Bahar Özvarış. “Evaluation of Turkish Validity and Reliability of the Cancer Stigma Scale”. Turkish Journal of Public Health, vol. 21, no. 2, Aug. 2023, pp. 196-08, doi:10.20518/tjph.1165240.
Vancouver
1.Çağla Susuz, Şevkat Bahar Özvarış. Evaluation of Turkish validity and reliability of the cancer stigma scale. TJPH. 2023 Aug. 1;21(2):196-208. doi:10.20518/tjph.1165240